ReviewCardiovascular drugs and therapy2022
Why Not Dipyridamole: a Review of Current Guidelines and Re-evaluation of Utility in the Modern Era.
Mahmoud Allahham et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it